AI is the buzzword startups are very keen on using when describing their products. For decades, movies are full of ideas on what artificial intelligence could do in a positive and negative way. What is AI, deep learning or a simple algorithm? What is the dream and what current reality around AI? How does AI look in practice?
In this episode, you will hear from Sally Daub – the CEO of Enlitic talk about the market potential of AI, the current state of the market and more. Enlitic is a San Francisco based startup using deep learning to distill actionable insights from billions of clinical cases and help doctors leverage the collective intelligence of the medical community.
At the moment, the use of AI is highest in the field of medical imaging and diagnostics, drug discovery and therapy planning, but Accenture predicts that by 2026 150 billion US dollars could be saved annually due to applications to robot-assisted surgery, virtual nursing assistants, followed by administrative workflow assistance, fraud detection and dosage error reduction, to name the first few areas with most significant savings.